Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 50(/LV1
=V1k'XJ
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© G.O0*E2V
l'VgS:NT
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© @<\f[Znt
o
L*9^-,
1.Co-stimulators (or co-stimulating molecules)
YcGSZ0vQ
t(Cd
oE,6
2.NK-kB 4-=> >#
P
` &|Rs
3.Immunoglobulin superfamily :KZI+
}3Pz{{B&+O
4.antigen-presenting cell (APC) Fg?Gx(g4
?};}#%971
5.death domain 3`J?as@^8
n
w @cAv
6.CCR and CXCR tz&=v,_jc
H]Q Z4(
7.Lectin (or mitogen) 0kpRvdEr-
Et%s,zeA{2
8.Clusters of differentiation, CD) O:RPH{D
i=reJ(y-
9.B7 family $uawQf+S
HLAWx/c,j"
10.Cytotoxic T lymphocyte, CTL) s9~W( Wi
<m`HK.|~
11.IL-15 and IL-15 receptor (IL-15R) }-)2CEj3L%
S,lJ&Rsu
12.MHC restriction [E2afC>zrl
HW"|Hm$Y(
13.Affinity-chromatography %z J)mOu
{~k/xM.-
14.Cyctosprin A, CsA $f*N
nu}$wLM
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) O!lZ%j@%
`&4L'1eF{
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© _$NFeqLww
?7@B$OlU
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 c#$B;?
>1,.4)k%K
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ A$WE:<^
VD;Ot<%
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ tjBs>w
\$/)o1SG
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ixw3Z D(>+
~urIA
/
ÃâÒßѧרҵ£º #gMMhB=
CuR\JKdRo
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ *j?tcxq
xM8}Xo
Ïû»¯ÄÚ¿Æ£º xKWqDt
T,@.RF
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 6B)(kPW
h
+.8Rl
ѪҺ²¡Ñ§×¨Òµ£º od{Y`
.<
y{,HpPp#o
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿